Work

Alveolar epithelial cell regeneration participates in luteolin alleviating acute lung injury via AMPK-PFKFB2 signaling-activated glycolysis

Year: 2026
Type: article
Abstract: Luteolin (Lut) is a natural flavonoid derived from numerous Chinese herbal medicines, which has been shown to alleviate acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Nevertheless, the specific mechanism through which it mediates alveolar repair during this pathological process has yet to be elucidated. In this study, network pharmacology was used to screen the effective components of traditional Chinese medicine for the treatment of ALI/ARDS, and the protective effect of Lut was observed by lipopolysaccharide (LPS)-induced ALI mouse model. The possible target protein and pathways of Lut were determined through proteomics and bioinformatics analysis. In addition, alveolar epithelial type (AT) 2 cells and three-dimensional alveolar organoid model were applied to explore the mechanisms of Lut in the repair of alveolar epithelium during ALI/ARDS. As a potential therapeutic agent for ALI/ARDS, Lut alleviated LPS-induced pulmonary edema in mice. Proteomic profiling combined with glucose metabolism assays in alveolar epithelial cells/organoids demonstrated that glycolysis-driven energy production was required for the Lut resolution of alveolar injury. Further bioinformatics analysis suggested that glycolysis-associated adenosine 5’-monophosphate-activated protein kinase (AMPK) might be involved in ALI/ARDS. Intriguingly, the proliferation of AT2 cells and their capacity to differentiate into AT1 cells were augmented following Lut administration, which was reversed when either an AMPK inhibitor was administrated or its binding kinase 6-phosphofructo-2-kinase/fructose − 2,6-bisphosphatase 2 (PFKFB2) was blocked. Lut may promote the regeneration of alveolar epithelial cells through enhancing glycolysis mediated by AMPK-PFKFB2 signaling pathway, thereby repairing the impaired alveoli and alleviating ALI/ARDS.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,190
OpenAlex ID: W7236827871
FWCI:
Cites:
Cited by:
Related to: 10